A drug dose model for predicting clinical outcomes in hypertensive coronary disease patients [0.03%]
William J Elliott,Ann C Hewkin,Stuart Kupfer et al.
William J Elliott et al.
To understand the effects of single- and multiple-drug combinations for hypertension on the risk of adverse clinical outcomes, the authors analyzed data from the International Verapamil SR/Trandolapril Study (INVEST). This trial randomized ...
Fagen Xie,Diana B Petitti,Joel Handler
Fagen Xie
An analysis was performed of the 1-year continued use of various antihypertensive agents in a health maintenance organization following the 2002 publication of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ...
Efficacy of combination therapy for systolic blood pressure in patients with severe systolic hypertension: the Systolic Evaluation of Lotrel Efficacy and Comparative Therapies (SELECT) study [0.03%]
Joel M Neutel,David H G Smith,Michael A Weber et al.
Joel M Neutel et al.
Systolic hypertension is predominant among patients over 50 years of age, is a more important cardiovascular risk factor than diastolic blood pressure, and is more difficult to control than diastolic blood pressure. Consequently, the Sevent...
Randomized Controlled Trial
Journal of clinical hypertension (Greenwich, Conn.). 2005 Nov;7(11):641-6; quiz 647-8. DOI:10.1111/j.1524-6175.2005.04615.x 2005
Barry L Carter,Jan Basile
Barry L Carter
Domenic A Sica,Rebecca Grubbs
Domenic A Sica
Transdermal clonidine was approved by the US Food and Drug Administration in 1984 for the treatment of mild-to-moderate hypertension alone or in combination with a diuretic. Clonidine is released from the patch at a constant rate and thus d...
Lower levels of microalbuminuria are associated with an increased risk of coronary heart disease and death in hypertensive subjects [0.03%]
微量白蛋白尿与高血压患者冠心病和死亡风险增加有关
Michael J Bloch,Jan Basile
Michael J Bloch
Ari Mosenkis,Raymond R Townsend
Ari Mosenkis
Randomized Controlled Trial
Journal of clinical hypertension (Greenwich, Conn.). 2005 Sep;7(9):554, 568. DOI:10.1111/j.1524-6175.2005.04126.x 2005
Thomas G Pickering
Thomas G Pickering
L Gabriel Navar
L Gabriel Navar
The devastating long-term consequences of high blood pressure include stroke, heart disease, atherosclerosis, renal disease, and other end-organ damage. From a physiologic perspective, it is not apparent why the propensity for hypertension ...
Barry J Materson
Barry J Materson